Monografie
Inhibition of Phosphodiesterase 4 (PDE4) Reduces Experimental Fibrosis by Interfering with the Release of Interleukin-6 from M2 Macrophages
- Sprache
-
Englisch
- Identifier
-
1128401576
Thema
Fibrosis; Systemic Sclerosis; Hautkrankheit; Dermatologie; Hochschulschrift
Beteiligte Personen und Organisationen
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:53 MEZ
Objekttyp
- Monografie
Ähnliche Objekte (12)
The transcription factors ATF3 and EN1 as regulators of the profibrotic effects of TGF beta signaling in the pathogenesis of Systemic Sclerosis
Evaluation of the efficacy of the tyrosine kinase inhibitor Nintedanib and characterization of the role of the tyrosine-phosphatase SHP2 in preclinical models of Systemic Sclerosis
Novel Insights into Hedgehog Signaling in Systemic Sclerosis at the level of GLI2 and HHAT and Characterization of the Role of the Orphan Nuclear Receptor RORα in Fibroblast Activation and Tissue Fibrosis
Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages
Inhibition of sumoylation prevents experimental fibrosis
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
1,064-nm Diode Laser Therapy of Onychomycosis: Results of a Prospective Open Treatment of 82 Toenails
Intracorneal Hematoma Showing Clinical and Dermoscopic Features of Acral Lentiginous Melanoma
Novel insights into the aberrant activation of fibroblasts in systemic sclerosis - Casein kinase 2, Poly(ADP-ribose)-Polymerase 1, and Janus kinase1 mediated transactivation of Janus kinase2 as novel players
The transcription factors ATF3 and EN1 as regulators of the profibrotic effects of TGF beta signaling in the pathogenesis of Systemic Sclerosis
Antihistamine updosing reduces disease activity in difficult-to-treat cholinergic urticaria patients
Die Veränderung der Lipidzusammensetzung in humanem Stratum corneum nach Induktion eines Hardening-Phänomens
The transcription factors ATF3 and EN1 as regulators of the profibrotic effects of TGF beta signaling in the pathogenesis of Systemic Sclerosis
Evaluation of the efficacy of the tyrosine kinase inhibitor Nintedanib and characterization of the role of the tyrosine-phosphatase SHP2 in preclinical models of Systemic Sclerosis
Novel Insights into Hedgehog Signaling in Systemic Sclerosis at the level of GLI2 and HHAT and Characterization of the Role of the Orphan Nuclear Receptor RORα in Fibroblast Activation and Tissue Fibrosis
Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages
Inhibition of sumoylation prevents experimental fibrosis
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
1,064-nm Diode Laser Therapy of Onychomycosis: Results of a Prospective Open Treatment of 82 Toenails
Intracorneal Hematoma Showing Clinical and Dermoscopic Features of Acral Lentiginous Melanoma
Novel insights into the aberrant activation of fibroblasts in systemic sclerosis - Casein kinase 2, Poly(ADP-ribose)-Polymerase 1, and Janus kinase1 mediated transactivation of Janus kinase2 as novel players
The transcription factors ATF3 and EN1 as regulators of the profibrotic effects of TGF beta signaling in the pathogenesis of Systemic Sclerosis
Antihistamine updosing reduces disease activity in difficult-to-treat cholinergic urticaria patients
Die Veränderung der Lipidzusammensetzung in humanem Stratum corneum nach Induktion eines Hardening-Phänomens
The transcription factors ATF3 and EN1 as regulators of the profibrotic effects of TGF beta signaling in the pathogenesis of Systemic Sclerosis
Evaluation of the efficacy of the tyrosine kinase inhibitor Nintedanib and characterization of the role of the tyrosine-phosphatase SHP2 in preclinical models of Systemic Sclerosis
Novel Insights into Hedgehog Signaling in Systemic Sclerosis at the level of GLI2 and HHAT and Characterization of the Role of the Orphan Nuclear Receptor RORα in Fibroblast Activation and Tissue Fibrosis
Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages
Inhibition of sumoylation prevents experimental fibrosis
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
1,064-nm Diode Laser Therapy of Onychomycosis: Results of a Prospective Open Treatment of 82 Toenails
Intracorneal Hematoma Showing Clinical and Dermoscopic Features of Acral Lentiginous Melanoma
Novel insights into the aberrant activation of fibroblasts in systemic sclerosis - Casein kinase 2, Poly(ADP-ribose)-Polymerase 1, and Janus kinase1 mediated transactivation of Janus kinase2 as novel players
The transcription factors ATF3 and EN1 as regulators of the profibrotic effects of TGF beta signaling in the pathogenesis of Systemic Sclerosis
Antihistamine updosing reduces disease activity in difficult-to-treat cholinergic urticaria patients